APSU/SHARC
APSU/SHARC
Pharmacotherapy and COVID-19 - Part 1 - Consumers respond
Pharmacotherapy and COVID-19 - Part 1 - Consumers respond
Pharmacotherapy and COVID-19 - Part 1 - Consumers respond
Tuesday 1st June 2021
Hear from consumers about the changes in pharmacotherapy during COVID-19, including telehealth benefits and financial barriers.
Explicit
18 minutes
Informative
Empowering
Compassionate
Thought-provoking
Supportive
About this podcast
Author:
APSU/SHARC
Overview:
Categories:
Family Recovery from Addiction
Understanding Addiction & Recovery
Sobriety Toolkit
Sexual Empowerment & Identity
Empowering Recovery Journeys
Links:
Visit site
Episodes:
33 (View all)
Do you want to link to this podcast?
Get the buttons here!Pharmacotherapy in a Pandemic: Consumers Speak Out
Despite these obvious benefits, there clearly are risks that policymakers will have to take into account and try to counteract if they choose to stick with the increased takeaways.
Imagine relying on a treatment that keeps you steady, then having the rules change overnight. That's what happened to many Victorians who depend on pharmacotherapy for opioid dependence when COVID-19 hit. This episode of 'Straight From the Source' dives into the real-life impact of these changes, straight from the mouths of those affected. You'll hear from a diverse group of consumers who share their firsthand experiences navigating this new landscape.
Michelle, one of the voices featured, talks about how telehealth made it easier to get her prescriptions, but also highlights the financial hurdles that still exist. The episode doesn't shy away from discussing policy implications either. What should stay, and what needs to go once the pandemic is over? The voices in this episode make a strong case for keeping some of the new measures, especially those that have made access easier for many.
If you're interested in understanding how the pandemic has reshaped addiction treatment and want to hear genuine stories from those living it, this episode is a must-listen.